{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T17:13:45Z","timestamp":1776532425297,"version":"3.51.2"},"reference-count":27,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[1985,9]]},"abstract":"<jats:p>A doen\u00e7a de Meige \u00e9 dist\u00farbio de movimento que consiste no aparecimento espont\u00e2neo de blefarospasmo associado a movimentos dist\u00f4nicos de musculatura orofacial. Associadamene podem ser encontrados torcicolo espasm\u00f3dico, disfonia esp\u00e1stica e distonia de extremidades. V\u00e1rias hip\u00f3teses foram formuladas para explicar esse dist\u00farbio, tendo em vista a resposta a drogas com a\u00e7\u00e3o conhecida nos sistemas de neurotransmissores do c\u00e9rebro. Algumas evid\u00eancias apontam para um estado de preponder\u00e2ncia dopamin\u00e9rgica e, nesse sentido, justifica-se a estimula\u00e7\u00e3o da atividade GABA, sabendo-se que esse neurotrans-missor age sobre uma das al\u00e7as de controle da produ\u00e7\u00e3o de dopamina na subst\u00e2ncia negra. Por essa raz\u00e3o investigamos a a\u00e7\u00e3o de um agonista GABA, o baclofen, sobre a doen\u00e7a de Meige. Foram inclu\u00eddos no protocolo 5 pacientes, 4 mulheres e um homem, com idade variando entre 50 e 63 anos e dura\u00e7\u00e3o da doen\u00e7a variando entre 4 meses e 18 anos. Todos apresentavam blefaros-pasmo-distonia orofacial e, al\u00e9m disso tr\u00eas apresentavam disfonia esp\u00e1stica e um distonia de extremidades. A droga era iniciada em dose de 20mg\/dia, aumentada em lOmg a cada tr\u00eas dias at\u00e9 ser obtida resposta ou surgirem efeitos colaterais. Um dos pacientes apresentou melhora marcada do blefaros-pasmo-distonia orofacial e outro melhora moderada dos mesmos sintomas, em avalia\u00e7\u00e3o 30 dias ap\u00f3s estabiliza\u00e7\u00e3o da dose. N\u00e3o houve melhora da disfonia esp\u00e1stica e ocorreu melhora moderada da distonia de extremidades. N\u00e3o podemos afirmar que a melhora observada ao fim de um m\u00eas se mantenha, ou mesmo que melhora mais significativa fosse observada em avalia\u00e7\u00e3o feita mais tardiamente. Concluimos que o baclofen pode ser \u00fatil, pelo menos por algum tempo, na doen\u00e7a de Meige.<\/jats:p>","DOI":"10.1590\/s0004-282x1985000300004","type":"journal-article","created":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T10:11:18Z","timestamp":1345025478000},"page":"260-266","source":"Crossref","is-referenced-by-count":7,"title":["Tratamento da doen\u00e7a de Meige com droga agonista de receptores GABA"],"prefix":"10.1590","volume":"43","author":[{"given":"Luiz Augusto Franco de","family":"Andrade","sequence":"first","affiliation":[{"name":"Escola Paulista de Medicina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Henrique Ferreira","family":"Bertolucci","sequence":"additional","affiliation":[{"name":"Escola Paulista de Medicina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/archneur.1972.00490120046004","article-title":"Spontaneous oral-facial dyskinesia","volume":"26","author":"ALTROCCHI RH.","year":"1972","journal-title":"Arch. Neurol."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/bmj.285.6345.853","article-title":"Efficacy of a combination of sodium valproate and baclofen in Meige's disease (idiopathic oro-facial dystonia","volume":"285","author":"BRENNAN M.J.W.","year":"1982","journal-title":"Brit. med. J.","ISSN":"https:\/\/id.crossref.org\/issn\/0267-0623","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1212\/WNL.30.7.690","article-title":"Pharmacology of blepharospasm-oromandibular dystonia syndrome","volume":"30","author":"CASEY D.E.","year":"1980","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref4","first-page":"112","article-title":"Treatment of blepharospasm with high-dose baclofen","volume":"14","author":"FAHN S.","year":"1983","journal-title":"Ann. Neurol."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/jnnp.44.5.437","article-title":"Brueghel's syndrome: report of a case with postmortem studies","volume":"44","author":"GARCIA-ALBEA E.","year":"1981","journal-title":"J. Neurol. Neurosurg. Psychiat."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJM197703032960916","article-title":"Facial dyskinesia after antihistamines","volume":"296","author":"GRANACHER R.P.","year":"1977","journal-title":"N. Engl. J. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ana.410110108","article-title":"Treatment of hyperkinetic movement disorders with tetrabenazine: a double-blind crossover study","volume":"11","author":"JANKOVTC J.","year":"1982","journal-title":"Ann. Neurol."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ana.410130406","article-title":"Blepharospasm and oro-facial-cervical dystonia: clinical and pharmacological findings in 100 patients","volume":"13","author":"JANKOVTC J.","year":"1983","journal-title":"Ann. Neurol."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1212\/WNL.33.9.1237","article-title":"Blepharospasm associated with brainstem lesions","volume":"33","author":"JANKOVTC J.","year":"1983","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/jnnp.39.12.1204","article-title":"Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome): A variant of adult-onset torsion dystonia?","volume":"39","author":"MARSDEN CD.","year":"1976","journal-title":"J. Neurol. Neurosurg. Psychiat."},{"key":"ref11","first-page":"225","article-title":"GABA and movement disorders","volume":"30","author":"MARSDEN CD","year":"1982","journal-title":"Adv. Biochem. Psychopharmac."},{"key":"ref12","first-page":"437","article-title":"Les convulsions de la face: Une forme clinique de convulsion faciale bilat\u00e9rale et m\u00e9diane","volume":"20","author":"MEIGE H.","year":"1910","journal-title":"Rev. Neurol."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1212\/WNL.32.4.432","article-title":"Beneficial effects of lisuride in Meige disease","volume":"32","author":"MICHELI F.","year":"1982","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref14","first-page":"359","article-title":"Cerebrospinal fluid GABA in neurological disease","volume":"28","author":"NEOPHYTIDES A.","year":"1978","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1212\/WNL.34.2.215","article-title":"Cranial dystonia: double-blind crossover study of anticholinergics","volume":"34","author":"NUTT J.G.","year":"1984","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref16","first-page":"69","article-title":"Meige's syndrome","volume":"27","author":"PAULSON G.W.","year":"1972","journal-title":"Geriatrics","ISSN":"https:\/\/id.crossref.org\/issn\/0016-867X","issn-type":"print"},{"key":"ref17","series-title":"Forma juvenil da s\u00edndrome de Brueghel-Marsden (Blefarospasmo e distonia oromandibular)","author":"POMPEU F.J.B.C.","year":"1979"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1001\/jama.1982.03320480060028","article-title":"Descongestant-induced blepharospasm and orofacial dystonia","volume":"247","author":"POWERS J.M.","year":"1982","journal-title":"J. amer. med. Assoc."},{"key":"ref19","first-page":"265","article-title":"Neuroleptic but not denervation-induced dopamine supersensitivity is blocked by lithium","volume":"32","author":"RUBIN E.H.","year":"1982","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref20","first-page":"147","article-title":"Treatment of Meige syndrome with cannabidiol","volume":"34","author":"SNIDER S.R.","year":"1984","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1212\/WNL.32.8.889","article-title":"Bromocriptine, physostigmine and neurotransmitter mechanisms in the dystonias","volume":"32","author":"STAHL S.M.","year":"1982","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref22","first-page":"445","article-title":"Pharmacologic characteristics of Meige dystonia: differentiation from tardive dyskinesia","volume":"43","author":"STAHL S.M.","year":"1982","journal-title":"J. clin. Psychiat."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1212\/WNL.32.7.783","article-title":"Meige disease: acute and chronic cholinergic effects","volume":"32","author":"TANNER C.M.","year":"1982","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1056\/NEJM197509042931008","article-title":"Oral-facial dyskinesia associated with prolonged use of antihistamine decongestants","volume":"293","author":"THATCH B.T.","year":"1975","journal-title":"N. Engl. J. Med.","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/archneur.1981.00510030041005","article-title":"Clinical features of Meige's disease (idiopathic orofacial dystonia): A report of 17 cases","volume":"38","author":"TOLOSA E.S.","year":"1981","journal-title":"Arch. Neurol."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1212\/WNL.29.8.1126","article-title":"Meige disease: striatal dopaminergic preponderance","volume":"29","author":"TOLOSA E.S.","year":"1979","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archneur.1982.00510190069027","article-title":"Meige's syndrome during long-term dopaminergic therapy in Parkinson's disease","volume":"39","author":"WEINER W.J.","year":"1982","journal-title":"Arch. Neurol."}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v43n3\/04.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T08:37:11Z","timestamp":1495874231000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X1985000300004&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,9]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985,9]]}},"alternative-id":["S0004-282X1985000300004"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x1985000300004","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,9]]}}}